Comments on: Daybagger Spiffy-Pop http://www.fusioninvesting.com/2009/09/daybagger-spiffy-pop/ Fusing Fundamental and Technical Analysis with lashings of Behavioural Finance. Investing in Australia and North America. Thu, 02 Feb 2012 06:57:27 +0000 hourly 1 http://wordpress.org/?v=3.2 By: Dean Morel http://www.fusioninvesting.com/2009/09/daybagger-spiffy-pop/comment-page-1/#comment-1215 Dean Morel Sat, 26 Sep 2009 00:31:06 +0000 http://www.fusioninvesting.com/?p=3387#comment-1215 miso I don't wish to start editing people's comments, but your comment is right on the edge of civility. I also disagree with the underlying assumptions and message. 1. The Relenza story is not the only example, it is almost the script for large pharma with a franchise to protect. 2. If not for bird flu and then swine flu, it was probable that it would have been something else; stockpile restocking, Tamiflu resistance. 3. BTA management probably made a mistake with the lawsuit, but that is old news. The Chairman and a director have since left the company. It is more fruitful to look forward. BTA management also bought back shares at around $0.70-.80 and more. Gotta go miso I don’t wish to start editing people’s comments, but your comment is right on the edge of civility. I also disagree with the underlying assumptions and message.
1. The Relenza story is not the only example, it is almost the script for large pharma with a franchise to protect.
2. If not for bird flu and then swine flu, it was probable that it would have been something else; stockpile restocking, Tamiflu resistance.
3. BTA management probably made a mistake with the lawsuit, but that is old news. The Chairman and a director have since left the company. It is more fruitful to look forward. BTA management also bought back shares at around $0.70-.80 and more.
Gotta go

]]> By: miso http://www.fusioninvesting.com/2009/09/daybagger-spiffy-pop/comment-page-1/#comment-1214 miso Fri, 25 Sep 2009 23:11:43 +0000 http://www.fusioninvesting.com/?p=3387#comment-1214 Relenza is also the only drug that has survived being wished gone by it's manufacturer GSK, more interested in it's "conflict of interest", influenza vaccines. If it hadn't been for bird flu, Relenza factories that had already been shut down, would have been bulldozed under by now. BTA management is equally indifferent, more interested in keeping profits away from shareholders than winning lawsuits and proving they aren't self-serving spineless wonders. The only thing shareholders can be proud of is the resilience of Relenza against all odds(not just influenza), and the brilliance of the scientists that discovered zanamivir and other antivirals. The only reason BTA is a good investment. Relenza is also the only drug that has survived being wished gone by it’s manufacturer GSK, more interested in it’s “conflict of interest”, influenza vaccines.
If it hadn’t been for bird flu, Relenza factories that had already been shut down, would have been bulldozed under by now.

BTA management is equally indifferent, more interested in keeping profits away from shareholders than winning lawsuits and proving they aren’t self-serving spineless wonders.

The only thing shareholders can be proud of is the resilience of Relenza against all odds(not just influenza), and the brilliance of the scientists that discovered zanamivir and other antivirals. The only reason BTA is a good investment.

]]> By: Dr. Jim http://www.fusioninvesting.com/2009/09/daybagger-spiffy-pop/comment-page-1/#comment-1176 Dr. Jim Tue, 15 Sep 2009 18:46:20 +0000 http://www.fusioninvesting.com/?p=3387#comment-1176 Relenza is the only drug that has had no flu resistance. If the flu hits big - it is the only guaranteed drug. Relenza is the only drug that has had no flu resistance. If the flu hits big – it is the only guaranteed drug.

]]>